Single Injection of High Volume of Autologous Pure PRP Provides a Significant Improvement in Knee Osteoarthritis: A Prospective Routine Care Study
Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activi...
Saved in:
Published in | International journal of molecular sciences Vol. 20; no. 6; p. 1327 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
15.03.2019
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 1422-0067 1661-6596 1422-0067 |
DOI | 10.3390/ijms20061327 |
Cover
Abstract | Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure. Methods: Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria. Results: A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters. Conclusion: A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital. |
---|---|
AbstractList | Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure.
Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria.
A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (
< 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (
< 0.001). No difference was observed on MRI parameters.
A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital. Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure. Methods: Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria. Results: A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters. Conclusion: A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital. Among them, platelet-rich plasma (PRP) is defined as an autologous plasma suspension of platelets, characterized by a platelet concentration higher than in physiological blood [9] and able to release growth factors (GFs) involved in reparative and regenerative processes. PRP has been the subject of increased clinical interest in the orthopaedic field and a recent meta analysis indicates that, compared with HA and saline, an intra-articular PRP injection may have more benefits in pain relief and functional improvement in patients with symptomatic knee OA at one year post-injection [10], providing orthopaedic surgeons and rheumatologists a new validated non-invasive option to improve knee OA related symptoms [11]. Substantial differences in the content of platelets concentrates produced by the various automated and manual protocols have been described [12,13] and their consequences on clinical results in PRP therapy is currently being investigated [14,15]. [...]the initiation of PRP injection activity within a hospital necessitates the selection of dedicated material and the establishment of a precise patient care procedure which should take into account recent recommendations from the AAOS regarding minimum reporting standards for clinical studies evaluating PRP [16]. [...]the medical device used in this study was validated in order to reach this condition. Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure. Methods: Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria. Results: A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure ( p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 ( p < 0.001). No difference was observed on MRI parameters. Conclusion: A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital. Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure.BACKGROUNDEvidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure.Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria.METHODSFifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria.A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters.RESULTSA single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters.A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital.CONCLUSIONA single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital. |
Author | Charpin, Caroline Benmenni, Annie Raffray, Marie Dehaut, Francois-Xavier Giorgi, Roch Arniaud, Denis Magalon, Jeremy Guillibert, Caroline El Ghobeira, Georges |
AuthorAffiliation | 4 Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Sciences Economiques et Sociales de la Santé & Traitement de l’Information Médicale, Hop Timone, BioSTIC, Biostatistique et Technologies de l’Information et de la Communication, 13005 Marseille, France; Roch.GIORGI@ap-hm.fr 1 Rheumatology Department, Hôpital Saint Joseph, 13008 Marseille, France; cguillibert@hopital-saint-joseph.fr (C.G.); ccharpin@hopital-saint-joseph.fr (C.C.); mraffray@hopital-saint-joseph.fr (M.R.); anbenmenni@hopital-saint-joseph.fr (A.B.); darniaud@hopital-saint-joseph.fr (D.A.) 3 Physical Therapy Department, Hôpital Saint Joseph, 13008 Marseille, France; gelghobeira@hopital-saint-joseph.fr 5 Cell Therapy Department, Hôpital de la Conception, AP-HM, INSERM CIC BT 1409, 13005 Marseille, France 2 Radiology Department, Hôpital Saint Joseph, 13008 Marseille, France; fxdehaut@hopital-saint-joseph.fr |
AuthorAffiliation_xml | – name: 5 Cell Therapy Department, Hôpital de la Conception, AP-HM, INSERM CIC BT 1409, 13005 Marseille, France – name: 1 Rheumatology Department, Hôpital Saint Joseph, 13008 Marseille, France; cguillibert@hopital-saint-joseph.fr (C.G.); ccharpin@hopital-saint-joseph.fr (C.C.); mraffray@hopital-saint-joseph.fr (M.R.); anbenmenni@hopital-saint-joseph.fr (A.B.); darniaud@hopital-saint-joseph.fr (D.A.) – name: 3 Physical Therapy Department, Hôpital Saint Joseph, 13008 Marseille, France; gelghobeira@hopital-saint-joseph.fr – name: 4 Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Sciences Economiques et Sociales de la Santé & Traitement de l’Information Médicale, Hop Timone, BioSTIC, Biostatistique et Technologies de l’Information et de la Communication, 13005 Marseille, France; Roch.GIORGI@ap-hm.fr – name: 2 Radiology Department, Hôpital Saint Joseph, 13008 Marseille, France; fxdehaut@hopital-saint-joseph.fr |
Author_xml | – sequence: 1 givenname: Caroline surname: Guillibert fullname: Guillibert, Caroline – sequence: 2 givenname: Caroline surname: Charpin fullname: Charpin, Caroline – sequence: 3 givenname: Marie surname: Raffray fullname: Raffray, Marie – sequence: 4 givenname: Annie surname: Benmenni fullname: Benmenni, Annie – sequence: 5 givenname: Francois-Xavier surname: Dehaut fullname: Dehaut, Francois-Xavier – sequence: 6 givenname: Georges surname: El Ghobeira fullname: El Ghobeira, Georges – sequence: 7 givenname: Roch surname: Giorgi fullname: Giorgi, Roch – sequence: 8 givenname: Jeremy orcidid: 0000-0003-1494-7011 surname: Magalon fullname: Magalon, Jeremy – sequence: 9 givenname: Denis surname: Arniaud fullname: Arniaud, Denis |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30884774$$D View this record in MEDLINE/PubMed https://inserm.hal.science/inserm-02551116$$DView record in HAL |
BookMark | eNptUk2P0zAQtdAi9gNunJElLhwoxB9JGg5IVQW0otJWW-BqOc44dZXYXduptH-DX4yj7i5lxWlmNG_ezJuZS3RmnQWEXpPsA2NV9tHs-kCzrCCMls_QBeGUTlJYnp345-gyhF2WUUbz6gU6Z9l0ysuSX6DfG2PbDvDS7kBF4yx2Gi9Mu8W_XDf0MIazIbrOtW4IeD14wOubNV57dzANBCzxxrTWaKOkjXjZ71MCeki-sfi7BcDXIYKTPm69iSZ8wrOxOOzHdgfAN26IxgKey8S8iUNz9xI917IL8OreXqGfX7_8mC8mq-tvy_lsNVGcV3ECjORFU-iq5lznU6Y0T-IYUYVUU5LXJaOsBimnnOq8bipVQ14yXTCdlFfJvUKfj7z7oe6hUWlmLzux96aX_k44acS_GWu2onUHUfCSkqpIBO-PBNsnZYvZShgbwPcio3lOCCkOJMHf3ffz7naAEEVvgoKukxbSbkXi5ITlySTo2yfQnRu8TdsQlLGEKAlhCfXmVMDjCA_XTQB6BKi08OBBC2WiHK-c9JhOkEyMLyROX-ivqseiB97_wv8AikzJEw |
CitedBy_id | crossref_primary_10_3390_ijms21041328 crossref_primary_10_7759_cureus_10575 crossref_primary_10_24938_kutfd_693499 crossref_primary_10_1155_2021_8808310 crossref_primary_10_3390_jpm13091309 crossref_primary_10_1007_s00266_022_02960_1 crossref_primary_10_1007_s00167_020_06102_5 crossref_primary_10_1016_j_arthro_2024_03_030 crossref_primary_10_1016_j_arthro_2021_03_074 crossref_primary_10_4103_jmupm_jmupm_3_23 crossref_primary_10_7759_cureus_70059 crossref_primary_10_1007_s12178_019_09573_3 crossref_primary_10_3390_jcm11082231 crossref_primary_10_1080_09537104_2020_1832653 crossref_primary_10_1177_1759720X221100304 crossref_primary_10_2147_JPR_S260878 crossref_primary_10_3390_bioengineering10080922 crossref_primary_10_1007_s11655_025_4208_z crossref_primary_10_1111_ijcp_14068 crossref_primary_10_3390_ijms23010472 crossref_primary_10_3390_jcm10112231 crossref_primary_10_1016_j_ocarto_2022_100318 crossref_primary_10_1186_s13018_022_03293_0 crossref_primary_10_1186_s13018_020_01753_z crossref_primary_10_20960_RevOsteoporosMetabMiner_00021 crossref_primary_10_2217_rme_2021_0032 crossref_primary_10_12677_ACM_2020_1012473 crossref_primary_10_1177_23259671241227863 crossref_primary_10_1186_s13018_024_05202_z crossref_primary_10_1016_j_bioadv_2025_214272 crossref_primary_10_3390_bioengineering10111276 crossref_primary_10_3390_jcm11092640 crossref_primary_10_1007_s12178_024_09922_x crossref_primary_10_1177_23259671211011948 crossref_primary_10_1007_s00264_020_04801_9 crossref_primary_10_1016_j_arthro_2024_03_002 crossref_primary_10_1186_s43055_024_01203_4 crossref_primary_10_3390_ijms20184581 crossref_primary_10_60118_001c_117195 crossref_primary_10_3390_jcm10081748 crossref_primary_10_1016_j_reth_2023_12_006 |
Cites_doi | 10.1148/radiol.2303021388 10.1097/00008505-200110000-00002 10.1002/art.24925 10.1016/j.joca.2010.09.013 10.1136/bmjsem-2015-000060 10.1001/jama.2018.19319 10.1016/j.arthro.2014.02.020 10.1177/0269215517724193 10.1136/ard.2008.092015 10.1016/j.arthro.2016.09.024 10.1016/j.arthro.2016.12.006 10.1186/s10195-018-0501-3 10.5435/JAAOS-D-18-00305 10.7326/0003-4819-116-7-535 10.1016/j.arthro.2017.11.035 10.2214/AJR.16.16243 10.5435/00124635-200910000-00006 10.1136/bmjsem-2018-000442 10.1177/0363546510387517 10.1177/0363546515580787 10.1007/s00402-016-2545-2 10.15585/mmwr.mm6519a2 |
ContentType | Journal Article |
Copyright | 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Distributed under a Creative Commons Attribution 4.0 International License 2019 by the authors. 2019 |
Copyright_xml | – notice: 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: 2019 by the authors. 2019 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 1XC VOOES 5PM |
DOI | 10.3390/ijms20061327 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database (ProQuest) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed Publicly Available Content Database MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | PMC6472196 oai_HAL_inserm_02551116v1 30884774 10_3390_ijms20061327 |
Genre | Journal Article |
GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 TUS UKHRP ~8M 3V. ABJCF BBNVY BHPHI GROUPED_DOAJ HCIFZ KB. M7P M~E NPM PDBOC 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 ESTFP PUEGO 1XC VOOES 5PM |
ID | FETCH-LOGICAL-c449t-e3156d6f9b44f583cf425931c6ac815b7323beaa842f5bd9cbe573f63f4779573 |
IEDL.DBID | M48 |
ISSN | 1422-0067 1661-6596 |
IngestDate | Thu Aug 21 18:03:49 EDT 2025 Fri Sep 12 12:39:39 EDT 2025 Sat Sep 27 23:24:48 EDT 2025 Fri Jul 25 20:23:38 EDT 2025 Wed Feb 19 02:35:13 EST 2025 Tue Jul 01 01:45:36 EDT 2025 Thu Apr 24 23:06:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | growth factors knee arthrosis PRP |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c449t-e3156d6f9b44f583cf425931c6ac815b7323beaa842f5bd9cbe573f63f4779573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 PMCID: PMC6472196 |
ORCID | 0000-0003-1494-7011 0000-0001-6135-3078 |
OpenAccessLink | https://www.proquest.com/docview/2332197113?pq-origsite=%requestingapplication%&accountid=15518 |
PMID | 30884774 |
PQID | 2332197113 |
PQPubID | 2032341 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6472196 hal_primary_oai_HAL_inserm_02551116v1 proquest_miscellaneous_2194135219 proquest_journals_2332197113 pubmed_primary_30884774 crossref_citationtrail_10_3390_ijms20061327 crossref_primary_10_3390_ijms20061327 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-03-15 |
PublicationDateYYYYMMDD | 2019-03-15 |
PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationTitleAlternate | Int J Mol Sci |
PublicationYear | 2019 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Barbour (ref_2) 2016; 65 Felson (ref_3) 1992; 116 Brown (ref_8) 2013; 21 (ref_15) 2016; 136 Rastogi (ref_18) 2016; 207 Gregori (ref_7) 2018; 320 Castillo (ref_13) 2011; 39 Magalon (ref_12) 2014; 30 Dai (ref_10) 2017; 33 Zhang (ref_23) 2008; 67 Lisi (ref_21) 2018; 32 Graiet (ref_24) 2018; 13 Hunt (ref_11) 2017; 33 Riboh (ref_14) 2016; 44 Marx (ref_9) 2001; 10 Woertler (ref_22) 2004; 230 Chu (ref_16) 2019; 27 Hepper (ref_5) 2009; 17 Magalon (ref_17) 2016; 2 Lane (ref_1) 2011; 19 Bannuru (ref_6) 2009; 61 (ref_20) 2018; 19 Louis (ref_19) 2018; 34 Bellamy (ref_4) 2006; 19 |
References_xml | – volume: 230 start-page: 768 year: 2004 ident: ref_22 article-title: Patellar articular cartilage lesions: in vitro MR imaging evaluation after placement in gadopentetate dimeglumine solution publication-title: Radiology doi: 10.1148/radiol.2303021388 – volume: 10 start-page: 225 year: 2001 ident: ref_9 article-title: Platelet-rich plasma (PRP): What is PRP and what is not PRP? publication-title: Implant Dent. doi: 10.1097/00008505-200110000-00002 – volume: 61 start-page: 1704 year: 2009 ident: ref_6 article-title: Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: A systematic review and meta-analysis publication-title: Arthritis Rheum. doi: 10.1002/art.24925 – volume: 19 start-page: 478 year: 2011 ident: ref_1 article-title: OARSI-FDA initiative: Defining the disease state of osteoarthritis publication-title: Osteoarthr. Cartil. doi: 10.1016/j.joca.2010.09.013 – volume: 2 start-page: e000060 year: 2016 ident: ref_17 article-title: DEPA classification: A proposal for standardising PRP use and a retrospective application of available devices publication-title: BMJ Open Sport Exerc. Med. doi: 10.1136/bmjsem-2015-000060 – volume: 320 start-page: 2564 year: 2018 ident: ref_7 article-title: Association of Pharmacological Treatments with Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis publication-title: JAMA doi: 10.1001/jama.2018.19319 – volume: 30 start-page: 629 year: 2014 ident: ref_12 article-title: Characterization and comparison of 5 Platelet-Rich Plasma preparations in a single donor model publication-title: Arthroscopy doi: 10.1016/j.arthro.2014.02.020 – volume: 32 start-page: 330 year: 2018 ident: ref_21 article-title: Treatment of knee osteoarthritis: Platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial publication-title: Clin. Rehabil. doi: 10.1177/0269215517724193 – volume: 67 start-page: 1716 year: 2008 ident: ref_23 article-title: The placebo effect and its determinants in osteoarthritis: Meta-analysis of randomised controlled trials publication-title: Ann. Rheum Dis. doi: 10.1136/ard.2008.092015 – volume: 19 start-page: CD005328 year: 2006 ident: ref_4 article-title: Intraarticular corticosteroid for treatment of osteoarthritis of the knee publication-title: Cochrane Database Syst. Rev. – volume: 33 start-page: 659 year: 2017 ident: ref_10 article-title: Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials publication-title: Arthroscopy doi: 10.1016/j.arthro.2016.09.024 – volume: 33 start-page: 671 year: 2017 ident: ref_11 article-title: Editorial Commentary: The Time Has Come to Try Intra-articular Platelet-Rich Plasma Injections for Your Patients with Symptomatic Knee Osteoarthritis publication-title: Arthroscopy doi: 10.1016/j.arthro.2016.12.006 – volume: 19 start-page: 3 year: 2018 ident: ref_20 article-title: Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: A randomized controlled trial publication-title: J. Orthop. Traumatol. doi: 10.1186/s10195-018-0501-3 – volume: 27 start-page: e50 year: 2019 ident: ref_16 article-title: Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations from the 2018 AAOS/NIH U-13 Conference publication-title: J. Am. Acad. Orthop. Surg. doi: 10.5435/JAAOS-D-18-00305 – volume: 116 start-page: 535 year: 1992 ident: ref_3 article-title: Weight loss reduces the risk for symptomatic knee osteoarthritis in woman. The Framingham Study publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-116-7-535 – volume: 34 start-page: 1530 year: 2018 ident: ref_19 article-title: Growth Factors Levels Determine Efficacy of Platelets Rich Plasma Injection in Knee Osteoarthritis: A Randomized Double Blind Noninferiority Trial Compared with Viscosupplementation publication-title: Arthroscopy doi: 10.1016/j.arthro.2017.11.035 – volume: 207 start-page: 484 year: 2016 ident: ref_18 article-title: Fundamentals of Joint Injection publication-title: Am. J. Roentgenol. doi: 10.2214/AJR.16.16243 – volume: 17 start-page: 638 year: 2009 ident: ref_5 article-title: The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: A systematic review of level I studies publication-title: J. Am. Acad. Orthop. Surg. doi: 10.5435/00124635-200910000-00006 – volume: 13 start-page: e000442 year: 2018 ident: ref_24 article-title: Use of platelet-rich plasma in regenerative medicine: Technical tools for correct quality control publication-title: BMJ Open Sport Exerc. Med. doi: 10.1136/bmjsem-2018-000442 – volume: 39 start-page: 266 year: 2011 ident: ref_13 article-title: Comparion of growth factor and platelet concentration from commercial platelet-rich plasma separation systems publication-title: Am. J. Sports Med. doi: 10.1177/0363546510387517 – volume: 44 start-page: 792 year: 2016 ident: ref_14 article-title: Effect of leukocyte concentration on the efficacy of Platelet rich Plasma in the treatment of knee osteoarthritis publication-title: Am. J. Sports Med. doi: 10.1177/0363546515580787 – volume: 136 start-page: 1723 year: 2016 ident: ref_15 article-title: Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis publication-title: Arch. Orthop. Trauma Surg. doi: 10.1007/s00402-016-2545-2 – volume: 65 start-page: 489 year: 2016 ident: ref_2 article-title: Prevalence of Doctor-Diagnosed Arthritis at State and County Levels—United States, 2014 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm6519a2 – volume: 21 start-page: 577 year: 2013 ident: ref_8 article-title: AAOS clinical practice guidelines. Treatment of osteoarthritis of the knee: Evidence-based guideline, 2ded publication-title: J. Am. Acad. Orthop. Surg. |
SSID | ssj0023259 |
Score | 2.4234674 |
Snippet | Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee... Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis... Among them, platelet-rich plasma (PRP) is defined as an autologous plasma suspension of platelets, characterized by a platelet concentration higher than in... |
SourceID | pubmedcentral hal proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1327 |
SubjectTerms | Arthritis Blood platelets Growth factors Life Sciences Pain Patients |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLa2Tki8IO6UDXSQ4AlFa2o7iZEQKmhTuZVoY2hvkZ04NNPmbGuLtL_BL-Yc58IKgrdEcZTLuX7253MYe16iFlg70gEGTxOIPNIBZvU2yEeh0ZGURVN4_vMsmh6JD8fyeIPNur0wRKvsfKJ31EWd0xz57phzNK44DPmb84uAukbR6mrXQkO3rRWK177E2CbbQpcsRwO29XZvlh70EIyPffu0EKNSEEkVNVR4jsB_tzo5WxC-RngWrwWpzTlRJP_OP_-kUV6LS_u32a02oYRJowF32IZ1d9mNpsXk1T328xBj06mF9-7Ek64c1CUQuQO-eb9Ep5OVb2JbrxaQri4tpAcppM0OvQVoOKy-OyIUoQygmYPwU4pQOfjorIUvqCg1auDc10d6BRO6udvBCUQ5wkwWaKMTEGvx6j472t_7-m4atH0YglwItQwsR5BXRKUyQpQy4XmJhq54iILNk1CamI-5sVonYlxKU6jcWBnzMuKliGOFhw_YwNXOPmKQaHRoKtE5oixhlFRS2pGRAkGhilC-Q_ay-_FZ3hYpp14ZpxmCFRJTdl1MQ_aiH33eFOf41ziUYT-EKmpPJ5-yyqGVn2WEqtDjRz_CIdvppJy1przIfivekD3rL6MR0sqKdhaFk-EATAak_4CHjVL0T-Pox_E_iCGL19Rl7XXWr7hq7gt9U2l_9JCP__9a2-wmZnGKiHGh3GGD5eXKPsFMaWmetur_CzPVE8Q priority: 102 providerName: ProQuest |
Title | Single Injection of High Volume of Autologous Pure PRP Provides a Significant Improvement in Knee Osteoarthritis: A Prospective Routine Care Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30884774 https://www.proquest.com/docview/2332197113 https://www.proquest.com/docview/2194135219 https://inserm.hal.science/inserm-02551116 https://pubmed.ncbi.nlm.nih.gov/PMC6472196 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFD5aNyHxgrgv26iMBE8o0NR2EiMhVNBKuY1oo6hvUZw6NFPnQi-I_g1-Mec4TbQykHipWsVRE5_rZ38-B-BRgVpgTCfzMXhqX-Rh5mNWb_y8E-gslHJcFZ7_eBIOhuLdSI52oO42upnAxV-hHfWTGs6nT39-X79Eg39BiBMh-7Py_GJByBiBVdSCPbdTRCQ-0ewnYNrg2qbRgodPDrqiwF-5eys4tSZEjbyad_5Jn7wUj_o34cYmkWS9SvK3YMfY23Ctai25vgO_zjAmTQ17a88d2cqyWcGI1MG-OH9EP3sr17wWsT9LVnPDktOEJdXJvAXL2Fn51RKRCOeeVWsPbimRlZa9t8awT6ggM9S8iauL9Jz16Ob65CYjqhFmsIwOODFiK67vwrB__Pn1wN_0X_BzIdTSNxzB3TgslBaikDHPCzRwxQMUaB4HUke8y7XJslh0C6nHKtdGRrwIeSGiSOHXe7BrZ9bsA4szdGQqznJEV0IrqaQ0HS0FgkEVotP04Ek98Wm-KU5OPTKmKYIUElN6WUwePG5Gf6uKcvxrHMqwGUKVtAe9D2lp0bovUkJT6OnDH4EHR7WU01oD0y7n-GBREHAPHjaX0fhoRyWzBoWT4gBUNule4H6lFM2_cfTfOA_Cg2hLXbYeZ_uKLSeuwDeV9EfPePCfr3kI1zGNU8SMC-QR7C7nK_MAU6WlbkMrGkX4GffftGHv1fFJctqm4CXbzj5-AxL6FtU |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB21qRC8IO64FFgk-oSsxt5dO4tUoQCtEpKGqDf1zaztdeOq3ZQmAeU3-CC-jRlfQgOCt77Z8sbeeM7OZX1mBuB1higwpqldNJ6xK5JAu-jVGzdperEOpEzLwvN7g6BzJD6dyJMV-FnnwhCtstaJhaJOxwntkW_5nOPiCj2Pv7v86lLXKPq6WrfQ0FVrhXS7KDFWJXb0zPw7hnCT7e5HlPem7-_uHH7ouFWXATcRQk1dwzGESYNMxUJkssWTDGGsuIfTTlqejEPu89ho3RJ-JuNUJbGRIc8CnokwVHiI912FNUEbKA1Ye78zGO4vQj7uF-3aPLSCbiBVUFLvOVfNrfzsYkLxPIaD4ZJRXB0RJfNvf_dP2uY1O7h7D-5WDixrl4i7DyvGPoBbZUvL-UP4cYC28Nywrj0rSF6WjTNGZBJ2XOhBOm3Piqa549mEDWdXhg33h2xYZgROmGYH-aklAhPKnJV7HsUWJsst61lj2GcE5hgRPyrqMb1lbfpxnTHKiOKEnjOjxCpGLMn5Izi6EYk8hoYdW_MUWEujAlUtnWBUJ2IllZSmGUuBQagKEE8OvKlffJRURdGpN8d5hMERiSm6LiYHNhejL8tiIP8ahzJcDKEK3p12P8otapWLiKI4tDDBN8-BjVrKUaU6JtFvoDvwanEZFz19ydHWoHAiHIDOhyz-wJMSFIuncbQb-B6EA-ESXJams3zF5qOisDi1EkCNvP7_ab2E253DvX7U7w56z-AOepCKSHme3IDG9GpmnqOXNo1fVEuBwZebXn2_AJ_6UFM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF21RSBeEHcMBQaJPiErsXfX9iIhFFGihJQSUYryZrzOmrhq16VOQPkNPoevY8aXtAHBW99seWNvPGdu67MzjD3PEAXGdBMXnad2RRokLkb1xk27nk4CKad14fn3-8HgULybyMkG-9XuhSFaZWsTK0M9LVJaI-_4nKNyhZ7HO1lDixjv9l-ffnOpgxR9aW3badQQGZnlD0zfylfDXZT1ju_33356M3CbDgNuKoSau4Zj-jINMqWFyGTE0wwhrLiHU04jT-qQ-1ybJImEn0k9Vak2MuRZwDMRhgoP8b6b7ErIhaC2EeHkPNnjftWozUP_5wZSBTXpnnPV7eRHJyVl8pgIhmvucHNGZMy_I90_CZsXPGD_JrvRhK7Qq7F2i20Ye5tdrZtZLu-wnwfoBY8NDO1RRe-yUGRANBL4XFlAOu0tqna5xaKE8eLMwPjjGMb1XsASEjjIv1qiLqG0oV7tqBYvIbcwssbAB4RkgVifVZWYXkKPftzuFQUiN2HMDLSlCogfubzLDi9FHvfYli2secAgStB0qihJMZ8TWkklpelqKTD9VAEiyWEv2hcfp005dOrKcRxjWkRiii-KyWE7q9GndRmQf41DGa6GUO3uQW8vzi3ak5OY8jf0LcF3z2HbrZTjxmiU8TnEHfZsdRnVnb7hJNagcGIcgGGHrP7A_RoUq6dx9Bj4HoTDwjW4rE1n_YrNZ1VJcWoigLb44f-n9ZRdQ52L94b7o0fsOoaOith4ntxmW_OzhXmM4dlcP6n0ANiXy1a833S8Te8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single+Injection+of+High+Volume+of+Autologous+Pure+PRP+Provides+a+Significant+Improvement+in+Knee+Osteoarthritis%3A+A+Prospective+Routine+Care+Study&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Guillibert%2C+Caroline&rft.au=Charpin%2C+Caroline&rft.au=Raffray%2C+Marie&rft.au=Benmenni%2C+Annie&rft.date=2019-03-15&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=20&rft.issue=6&rft.spage=1327&rft_id=info:doi/10.3390%2Fijms20061327&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms20061327 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |